Table 1.
Distribution of DEK Status in Non–Small Cell Lung Cancer According to Clinicopathological Characteristics.
| Characteristics | No. of Patients | DEK Negative, No. (%) | DEK Positive, No. (%) | χ2 Value | P Value |
|---|---|---|---|---|---|
| Age, y | |||||
| <60 | 51 | 22 (43.1) | 29 (56.9) | 0.165 | 0.684 |
| ≥60 | 61 | 24 (39.3) | 37 (60.7) | ||
| Sex | |||||
| Male | 72 | 28 (38.9) | 44 (61.1) | 0.397 | 0.529 |
| Female | 40 | 18 (45.0) | 22 (55.0) | ||
| Histology | |||||
| Adenocarcinoma | 64 | 21 (32.8) | 43 (67.2) | 4.209 | 0.040* |
| Squamous cell carcinoma | 48 | 25 (52.1) | 23 (47.9) | ||
| Differentiation | |||||
| Well | 41 | 16 (39.0) | 25 (61.0) | 13.373 | 0.001* |
| Moderate | 47 | 27 (57.4) | 20 (42.6) | ||
| Poor | 24 | 3 (12.5) | 21 (87.5) | ||
| TNM stage | |||||
| I | 55 | 28 (50.9) | 27 (49.1) | 8.130 | 0.017* |
| II | 33 | 14 (42.4) | 19 (57.6) | ||
| III | 24 | 4 (16.7) | 20 (83.3) | ||
| Tumor status | |||||
| T1 | 59 | 25 (42.4) | 34 (57.6) | 0.087 | 0.768 |
| T2, T3, and T4 | 53 | 21 (39.6) | 32 (60.4) | ||
| Lymph node metastasis | |||||
| N0 | 69 | 34 (49.3) | 35 (50.7) | 4.998 | 0.025* |
| N1, N2, and N3 | 43 | 12 (27.9) | 31 (72.1) | ||
*
p<0.05 was considered significant.